Biologic therapies for refractory juvenile dermatomyositis: Five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
C. H. Spencer*, K. Rouster-Stevens, H. Gewanter, G. Syverson, R. Modica, K. Schmidt, H. Emery, C. Wallace, S. Grevich, K. Nanda, Y. D. Zhao, S. Shenoi, S. Tarvin, S. Hong, C. Lindsley, J. E. Weiss, M. Passo, K. Ede, A. Brown, K. ArdalanW. Bernal, M. L. Stoll, B. Lang, R. Carrasco, C. Agaiar, L. Feller, H. Bukulmez, R. Vehe, H. Kim, H. Schmeling, D. Gerstbacher, M. Hoeltzel, B. Eberhard, R. Sundel, S. Kim, A. M. Huber, A. Patwardhan, Leslie Abramson, Dania Basodan, Johanna Chang, Megan Curran, Kyla Driest, Polly Ferguson, Daniel Horton, Kristin Houghton, Maria Ibarra, Esra Meidan, Marc Natter, Miriam Parsa, Reshma Patel, Pediatric Rheumatologist Collaborators
Dive into the research topics of 'Biologic therapies for refractory juvenile dermatomyositis: Five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America'. Together they form a unique fingerprint.